Leah Zuroff

604 total citations
15 papers, 373 citations indexed

About

Leah Zuroff is a scholar working on Neurology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Leah Zuroff has authored 15 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 4 papers in Pathology and Forensic Medicine and 3 papers in Physiology. Recurrent topics in Leah Zuroff's work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Multiple Sclerosis Research Studies (4 papers) and Alzheimer's disease research and treatments (3 papers). Leah Zuroff is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Multiple Sclerosis Research Studies (4 papers) and Alzheimer's disease research and treatments (3 papers). Leah Zuroff collaborates with scholars based in United States, China and Australia. Leah Zuroff's co-authors include Keith L. Black, Maya Koronyo‐Hamaoui, David A. Daley, Amit Bar‐Or, Rui Li, Alice Chen‐Plotkin, Koji Shinoda, Roy N. Alcalay, Ayman Rezk and Joyce A. Benjamins and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Frontiers in Immunology.

In The Last Decade

Leah Zuroff

15 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leah Zuroff United States 9 161 157 84 65 58 15 373
Çiğdem Acıoğlu United States 9 167 1.0× 105 0.7× 122 1.5× 78 1.2× 59 1.0× 11 424
Peter Bor‐Chian Lin United States 10 201 1.2× 185 1.2× 158 1.9× 63 1.0× 50 0.9× 27 434
Brooke A. Keating Australia 8 75 0.5× 130 0.8× 105 1.3× 71 1.1× 37 0.6× 15 347
Lynn van Olst Netherlands 10 200 1.2× 142 0.9× 155 1.8× 76 1.2× 34 0.6× 13 429
Marios Kritsilis Sweden 5 93 0.6× 149 0.9× 137 1.6× 39 0.6× 37 0.6× 5 368
Ryan J. Bevan United Kingdom 12 159 1.0× 85 0.5× 107 1.3× 101 1.6× 47 0.8× 19 393
Oihana Errea Spain 4 176 1.1× 69 0.4× 149 1.8× 85 1.3× 47 0.8× 6 481
A Ciechanowska Poland 12 76 0.5× 143 0.9× 68 0.8× 78 1.2× 75 1.3× 26 358
Sean Ott United States 10 117 0.7× 141 0.9× 76 0.9× 41 0.6× 73 1.3× 14 431
Davis Borucki United States 11 176 1.1× 54 0.3× 202 2.4× 110 1.7× 62 1.1× 13 459

Countries citing papers authored by Leah Zuroff

Since Specialization
Citations

This map shows the geographic impact of Leah Zuroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah Zuroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah Zuroff more than expected).

Fields of papers citing papers by Leah Zuroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah Zuroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah Zuroff. The network helps show where Leah Zuroff may publish in the future.

Co-authorship network of co-authors of Leah Zuroff

This figure shows the co-authorship network connecting the top 25 collaborators of Leah Zuroff. A scholar is included among the top collaborators of Leah Zuroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah Zuroff. Leah Zuroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zuroff, Leah, et al.. (2025). The Road to Remyelination in Multiple Sclerosis: Breakthroughs, Challenges, and Considerations for Future Trial Design. Drugs. 85(11). 1337–1362. 1 indexed citations
2.
Zuroff, Leah, Amanda C. Guidon, Grant T. Liu, et al.. (2024). Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States. Neurology Clinical Practice. 14(5). e200335–e200335. 1 indexed citations
3.
Zuroff, Leah & Ari Green. (2024). The Study of Remyelinating Therapies in Multiple Sclerosis: Visual Outcomes as a Window Into Repair. Journal of Neuro-Ophthalmology. 44(2). 143–156. 1 indexed citations
4.
Thebault, Simon, Leah Zuroff, Matthew K. Schindler, et al.. (2023). Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 8 indexed citations
5.
Touil, Hanane, Rui Li, Leah Zuroff, et al.. (2023). Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis. EBioMedicine. 96. 104789–104789. 32 indexed citations
6.
Zuroff, Leah, Laura E.M. Wisse, Sharon X. Xie, et al.. (2022). Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline. Journal of Alzheimer s Disease Reports. 6(1). 411–430. 9 indexed citations
7.
Zuroff, Leah, Ayman Rezk, Koji Shinoda, et al.. (2022). Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age. EBioMedicine. 82. 104179–104179. 29 indexed citations
8.
Turner, Brandon E., Christopher J. Magnani, Alexander Frolov, et al.. (2021). Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reporting. Journal of the Neurological Sciences. 428. 117579–117579. 7 indexed citations
9.
Li, Rui, Thomas F. Tropea, Leah Zuroff, et al.. (2021). Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease. Neurology Neuroimmunology & Neuroinflammation. 9(2). 36 indexed citations
10.
Kahn, Benjamin, Sokratis A. Apostolidis, Allison R. Greenplate, et al.. (2021). Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination. Critical Care Explorations. 3(11). e0578–e0578. 13 indexed citations
11.
Wilcox, Nicholas S., Chantal Tapé, Leah Zuroff, et al.. (2021). Anemia in a young Guinean male. SHILAP Revista de lepidopterología. 9(8). e04593–e04593. 1 indexed citations
12.
Zuroff, Leah, Tania Torbati, Dieu‐Trang Fuchs, et al.. (2020). Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ42 Assemblies. Frontiers in Immunology. 11. 1449–1449. 18 indexed citations
13.
Zuroff, Leah, Joyce A. Benjamins, Amit Bar‐Or, & Robert P. Lisak. (2020). Inflammatory mechanisms underlying cortical injury in progressive multiple sclerosis. Neuroimmunology and Neuroinflammation. 2020. 111–133. 8 indexed citations
14.
Zuroff, Leah, David A. Daley, Keith L. Black, & Maya Koronyo‐Hamaoui. (2017). Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes. Cellular and Molecular Life Sciences. 74(12). 2167–2201. 204 indexed citations
15.
Campo, Marta del, Leah Zuroff, Connie R. Jiménez, Philip Scheltens, & Charlotte E. Teunissen. (2015). Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 1(1). 75–80. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026